100 Participants Needed

Dietary Intervention for Type 2 Diabetes

(DECIDE Trial)

BO
Overseen ByBarbara Oliveira, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether dietary changes can put type 2 diabetes into remission, achieving normal blood sugar levels without medication. Participants will follow either a low-calorie diet, featuring pre-packaged foods and dietitian guidance, or a low-carbohydrate diet, which limits carbs and is customized to individual needs. The trial aims to determine which diet better manages diabetes. It may suit individuals diagnosed with type 2 diabetes who struggle with high blood sugar levels, are open to new diets, and have no dietary restrictions. As an unphased trial, it offers a unique opportunity to explore innovative dietary approaches to managing diabetes.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that both low-calorie and low-carbohydrate diets have been studied for safety in people with type 2 diabetes. Studies have found that very low-calorie diets can significantly improve blood sugar levels. These diets often include meal replacements and are generally well-tolerated, though some people may feel hungry or tired.

Research has shown that the low-carbohydrate diet effectively manages blood sugar without major safety concerns. Some people might experience initial side effects like headaches or tiredness, but these usually improve over time. Both diets have been studied in different settings and are considered safe for most people with type 2 diabetes. Consulting a healthcare provider is important to ensure the diet is appropriate.12345

Why are researchers excited about this trial?

Researchers are excited about these dietary interventions for Type 2 Diabetes because they offer potential lifestyle-based alternatives to traditional treatments like medication. The low-calorie diet emphasizes structured meal plans with pre-packaged foods, which can make it easier for individuals to follow and maintain weight loss, a crucial factor in managing diabetes. On the other hand, the low-carbohydrate diet allows for personalized adjustments and focuses on whole foods, potentially improving blood sugar control by reducing daily carb intake. Both approaches aim to empower patients with options that could improve adherence and overall health outcomes without relying solely on pharmacological interventions.

What evidence suggests that this trial's dietary interventions could be effective for type 2 diabetes remission?

This trial will compare a low-calorie diet with a low-carbohydrate diet for managing type 2 diabetes. Research has shown that eating fewer calories can help some people with type 2 diabetes normalize their blood sugar without medication. One study found that this approach can also lower the risk of heart disease. For low-carbohydrate diets, research indicates they can help control blood sugar and lead to weight loss. In one study, more than half of the participants on a low-carb diet saw their diabetes go into remission after six months. Both diet options appear promising for effectively managing type 2 diabetes.14678

Are You a Good Fit for This Trial?

This trial is for adults aged 20-80 with Type 2 Diabetes, an HbA1c level of at least 6.0%, and a BMI over 27 kg/m2. Participants should be able to follow a low-calorie or low-carbohydrate diet without dietary restrictions and must have internet access. Those who've recently lost weight, had bariatric surgery, severe mental health issues, recent serious illnesses like cancer or heart disease, eating disorders, or are pregnant can't join.

Inclusion Criteria

Your HbA1c level is 6.0% or higher.
You weigh more than what is considered healthy for your height.
I am between 20 and 80 years old.
See 2 more

Exclusion Criteria

I have lost 5% or more of my weight in the past 6 months.
I have a history of liver disease.
You have food allergies or dietary restrictions that would make it hard for you to follow the diet plan.
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase 1: Weight Loss and Medication Deprescribing

Participants undergo a weight loss program and medication deprescribing

12 weeks
In-person and virtual appointments

Phase 2: Transition to Sustainable Dietary Pattern

Participants transition to an individualized sustainable dietary pattern

8 weeks
Virtual visits

Phase 3: Weight Loss/Remission Maintenance

Participants maintain weight loss and diabetes remission

32 weeks
In-person and virtual appointments

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Low-calorie diet or low-carbohydrate diet
Trial Overview The study explores whether Type 2 Diabetes can go into remission through diet alone—without medications. It compares the effectiveness of a low-calorie diet versus a low-carbohydrate diet on lowering blood sugar levels to normal ranges.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Low-carbohydrate diet groupExperimental Treatment1 Intervention
Group II: Low-calorie diet groupExperimental Treatment1 Intervention

Low-calorie diet or low-carbohydrate diet is already approved in European Union, United Kingdom, United States for the following indications:

🇪🇺
Approved in European Union as Therapeutic Nutrition for:
🇬🇧
Approved in United Kingdom as Low-Calorie Diet for:
🇺🇸
Approved in United States as Low-Carbohydrate Diet for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

Published Research Related to This Trial

In a study of 229 obese type 2 diabetic patients over 24 weeks, a protein-sparing modified formula diet (FD) led to significantly greater weight loss (-3.5 kg) compared to a conventional low-caloric diet (CD) (-1.4 kg), indicating its efficacy for weight management.
The FD group also showed more significant improvements in metabolic health, including greater reductions in HbA1c and increases in HDL-cholesterol, suggesting that this diet not only aids in weight loss but also enhances cardiovascular risk factors.
The effects of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients--multicenter trial.Shirai, K., Saiki, A., Oikawa, S., et al.[2022]
Nutritional therapy for type II diabetes can be effective, but it requires realistic weight loss goals and proper meal planning, including meal splitting and carbohydrate distribution, rather than just cutting out carbs.
Not all type II diabetic patients respond to dietary changes alone; some may need additional treatments like oral medications or insulin, and involving dieticians can enhance long-term success in managing the condition.
[Why does nutrition therapy so often fail in non-insulin-dependent diabetes? What measures bring success?].Keller, U.[2015]
A very-low-calorie diet (VLCD) of 600 kcal/day was effective in inducing short-term remission of type 2 diabetes in 79% of the 19 Thai patients studied, with significant improvements in glycemic control and beta cell function observed within the first 2 weeks.
After 12 months, about 30% of participants maintained diabetes remission without medication, indicating that while VLCD can provide rapid benefits, long-term maintenance of glycemic control may require additional strategies.
Immediate and long-term effects of a very-low-calorie diet on diabetes remission and glycemic control in obese Thai patients with type 2 diabetes mellitus.Umphonsathien, M., Prutanopajai, P., Aiam-O-Ran, J., et al.[2023]

Citations

Low-energy total diet replacement intervention in patients ...Our objective was to examine the effect of a low-energy total diet replacement (TDR) intervention versus standardized dietetic care in patients ...
Efficacy of a Homemade Very Low Calorie Diet to Achieve ...Very low calorie diets have achieved remission of type 2 diabetes in obese individuals and lowered cardiovascular risk.
A Pathway to Type 2 Diabetes Remission: WeightThis article reports on the feasibility and effectiveness of a 12-week program, including a low-calorie diet using a diabetes-specific nutritional formula ...
The latest evidence and clinical guidelines for use of meal ...Acceptability of a very-low-energy diet in type 2 diabetes ... Efficacy and safety of meal replacement in patients with type 2 diabetes.
Analysis shows low energy diets with formula meal ...Low energy diets with formula meal replacements are the most effective methods of weight management and remission in adults with type 2 diabetes (T2D).
The impact of low-energy total diet replacement with ...We aim to investigate if the TDR programme is non-inferior to standard care in terms of disordered eating in susceptible individuals.
Remission of Type 2 Diabetes with Very Low-Calorie Diets ...A body of evidence demonstrates that adherence to VLCD in adults with type 2 diabetes (T2D) can result in marked improvements to glycemic control and even full ...
Nutrition Interventions for Remission of Type 2 DiabetesStudies of nonsurgical weight loss have found that low- calorie and very-low-calorie diets using meal replace- ments are an effective method for achieving ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security